肥厚型心肌病女性的妊娠结局:ROPAC注册研究
结果显示无孕产妇死亡,23%发生主要不良心血管事件(MACE),以心衰和心律失常为主,多发生于妊娠晚期和产后期;孕前NYHA≥II级及心衰征象与MACE相关。
要点
- 肥厚型心肌病孕妇虽多可耐受妊娠,但MACE发生率为23%,其中心衰15%、心律失常12%。
- MACE最常发生于妊娠晚期和产后期,需加强该时段监测。
- 孕前NYHA≥II级和心衰征象与MACE相关,应重视孕前咨询。
核心结论
- 多数肥厚型心肌病女性可耐受妊娠,但心血管并发症并不少见,且可由孕前状态预测,有助于孕前咨询和针对性产前保健。
研究设计与样本
- 比较发生MACE与未发生MACE、以及梗阻性与非梗阻性肥厚型心肌病患者基线和结局数据。
主要发现
- 无孕产妇死亡;14例(23%)发生至少1次MACE,其中心衰9例(15.0%)、心律失常7例(12%)。
- MACE最常发生于妊娠晚期和产后期;3例(5.0%)发生胎儿丢失。
- 发生MACE者因心脏原因紧急剖宫产率更高(21.4% vs. 0%,P=0.01)。
- 梗阻性与非梗阻性肥厚型心肌病患者的妊娠结局无显著差异。
- 孕前NYHA功能分级≥II级及心衰征象与MACE相关。
临床怎么用
- 孕前应评估NYHA分级和心衰征象以识别高危患者,并据此进行孕前咨询。
- 妊娠晚期和产后期需加强心血管监测,警惕心衰和心律失常。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: We report the maternal and foetal outcomes at birth and after 6 months in a cohort of pregnant women with hypertrophic cardiomyopathy (HCM). Although most women with HCM tolerate pregnancy well, there is an increased risk of obstetric and cardiovascular complications. METHODS AND RESULTS: All pregnant women with HCM entered into the prospective worldwide Registry of Pregnancy and Cardiac disease (ROPAC) were included in this analysis. The primary endpoint was a major adverse cardiovascular event (MACE), which included death, heart failure (HF), thrombo-embolic event, and arrhythmia. Baseline and outcome data were analysed and compared for patients with MACE vs. without MACE and for patients with obstructive HCM vs. non-obstructive HCM. Sixty pregnant women (mean age 30.4 ± 6.0 years) with HCM (41.7% obstructive) were included. No maternal mortality occurred in this cohort. In 14 (23%) patients at least one MACE occurred: 9 (15.0%) HF and 7 (12%) an arrhythmia (6 ventricular and 1 atrial fibrillation). MACE occurred most commonly during the 3rd trimester and postpartum period. In total, 3 (5.0%) women experienced foetal loss. Women with MACE had a higher rate of emergency Caesarean delivery for cardiac reasons (21.4% vs. 0%, P = 0.01). No significant differences in pregnancy outcome were found between women with obstructive and non-obstructive HCM. NYHA functional class of ≥II and signs of HF before pregnancy, were associated with MACE. CONCLUSION: Although most women with HCM tolerated pregnancy well, cardiovascular complications were not uncommon and predicted by pre-pregnancy status facilitating pre-pregnancy counselling and targeted antenatal care.
引用
- Goland S, van Hagen IM, Elbaz-Greener G, et al. Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC). Eur Heart J. 2017. PMID: 28934836. doi:10.1093/eurheartj/ehx189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。